Cargando…
Management of Multisystem Inflammatory Syndrome in Children: Decision-Making Regarding a New Condition in the Absence of Clinical Trial Data
Multisystem inflammatory syndrome in children (MIS-C) is a new illness that evolved during the COVID-19 pandemic with initial reports of severe disease including use of extracorporeal membrane oxygenation and death. Institutions rapidly assembled task forces to develop treatment algorithms. At the n...
Autores principales: | Harahsheh, Ashraf S., Portman, Michael A., Khoury, Michael, Elias, Matthew D., Lee, Simon, Lin, Justin, McCrindle, Brian W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Canadian Cardiovascular Society. Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705008/ https://www.ncbi.nlm.nih.gov/pubmed/36455760 http://dx.doi.org/10.1016/j.cjca.2022.11.011 |
Ejemplares similares
-
SARS-CoV-2 Variants and Multisystem Inflammatory Syndrome in Children
por: McCrindle, Brian W., et al.
Publicado: (2023) -
Kawasaki Disease Shock Syndrome vs Classical Kawasaki Disease: A Meta-analysis and Comparison With SARS-CoV-2 Multisystem Inflammatory Syndrome
por: Lamrani, Loubna, et al.
Publicado: (2021) -
Emerging Insights Into the Pathophysiology of Multisystem Inflammatory Syndrome Associated With COVID-19 in Children
por: Lin, Justin, et al.
Publicado: (2023) -
Management of Multisystem Inflammatory Syndrome in Children Associated With COVID-19: A Survey From the International Kawasaki Disease Registry
por: Elias, Matthew D., et al.
Publicado: (2020) -
Reply
por: Harahsheh, Ashraf S., et al.
Publicado: (2020)